
About Hummsa Biotech Private Limited
Data last updated:
Hummsa Biotech Private Limited is a private limited company based in Kolkata, West Bengal, India, recognised as a startup by DPIIT. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 26 April 2022.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB2022PTC253326. Its GSTIN is 19AAGCH2757J1Z7 (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.41 Lakh. It is led by directors Harshad Lalwani and Mayukh Bose.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2/A Rakhal Mukhrjee Rd, Kolkata, West Bengal, India – 700025.
As per the financials filed for FY 2024, the company reported a revenue of ₹20,000, a decline of 33% compared to the previous year. For the same year it recorded a net loss of ₹14.49 Lakh and EBITDA of -₹14.24 Lakh.
The company is associated with 1 brand: Hummsa Biotech. The company has 2 deals on record (1 convertible or debt financing, 1 funding round), with disclosed funding of ₹2.18 Cr; the latest was in February 2024.
For more details, the company can be reached via its website hummsabiotech.com.
Company details
Recognitions & Rankings of Hummsa Biotech
Contact details
Hummsa Biotech Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.
- Email
- Social Media
- Registered Address2/A Rakhal Mukhrjee Rd, Kolkata, West Bengal, India – 700025
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Hummsa Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Hummsa Biotech operates one associated brand: Hummsa Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Nanotechnology-based diagnostic devices for various diseases are developed. | hummsabiotech.com |
Business activity
The main business activity of Hummsa Biotech is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Hummsa Biotech Private Limited, buy the company report.
Financials of Hummsa Biotech Private Limited
FY 2025 filings availableHummsa Biotech Private Limited reported revenue of ₹20,000 (down 33% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 33% in the latest year. EBITDA fell 19% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹14.24 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹14.49 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Hummsa Biotech Private Limited, buy the company report.
Board of directors of Hummsa Biotech Private Limited
Hummsa Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harshad Lalwani | Director | 26 Apr 2022 | 4 Years 6 Months | Current |
| Mayukh Bose Also directs: Aurevion Bio Private Limited, Binfosol Private Limited | Director | 22 Aug 2024 | 2 Years 2 Months | Current |
Auditor
Hummsa Biotech Private Limited is audited by MRG & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MRG & CO | FY 2023 | 301045E |
Shareholding
The shareholding of Hummsa Biotech Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Hummsa Biotech Private Limited, buy the company report.
Deals & funding
Hummsa Biotech Private Limited has 2 deals on record (1 convertible or debt financing, 1 funding round), with disclosed funding of ₹2.18 Cr; the latest was in February 2024.
To see the full deal history of Hummsa Biotech Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Hummsa Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hummsa Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hummsa Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAGCH2757J1Z7 | West Bengal | Active | 17 May 2022 |
To see the full GST registrations and return filing status of Hummsa Biotech Private Limited, buy the company report.
Recent activity
Hummsa Biotech Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Mayukh Bose was appointed as Director on 22 Aug 2024.
Frequently asked questions
Hummsa Biotech is an active private limited company based in Kolkata, West Bengal, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 26 April 2022 (4+ years old) and is registered under CIN U24239WB2022PTC253326.
Hummsa Biotech has 2 current directors:
- Harshad Lalwani - Director
- Mayukh Bose - Director
The latest financial statements of Hummsa Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Hummsa Biotech is 19AAGCH2757J1Z7, registered in West Bengal.
The CIN (Corporate Identification Number) of Hummsa Biotech is U24239WB2022PTC253326. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hummsa Biotech was incorporated on 26 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kolkata.
Hummsa Biotech has 2 deals on record (1 convertible or debt financing, 1 funding round), with disclosed funding of ₹2.18 Cr; the latest was in February 2024.
Mayukh Bose was appointed as Director on 22 Aug 2024. Sanjana Malhotra ceased to be Director on 22 Aug 2024. Harshad Lalwani was appointed as Director on 26 Apr 2022.
Yes, Hummsa Biotech is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Hummsa Biotech can be reached through the website hummsabiotech.com. Its registered office is in Kolkata, West Bengal, India.

